- Home
- RARE vs MOD Comparison
RARE vs MOD Comparison
Compare RARE & MOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RARE
- MOD
- Stock Information
- Founded
- RARE 2010
- MOD 1916
- Country
- RARE United States
- MOD United States
- Employees
- RARE N/A
- MOD N/A
- Industry
- RARE Biotechnology: Pharmaceutical Preparations
- MOD Auto Parts:O.E.M.
- Sector
- RARE Health Care
- MOD Consumer Discretionary
- Exchange
- RARE Nasdaq
- MOD Nasdaq
- Market Cap
- RARE 5.2B
- MOD 6.1B
- IPO Year
- RARE 2014
- MOD N/A
- Fundamental
- Price
- RARE $40.89
- MOD $139.67
- Analyst Decision
- RARE Strong Buy
- MOD Strong Buy
- Analyst Count
- RARE 15
- MOD 5
- Target Price
- RARE $92.00
- MOD $128.25
- AVG Volume (30 Days)
- RARE 1.0M
- MOD 617.4K
- Earning Date
- RARE 02-13-2025
- MOD 01-28-2025
- Dividend Yield
- RARE N/A
- MOD N/A
- EPS Growth
- RARE N/A
- MOD N/A
- EPS
- RARE N/A
- MOD 3.04
- Revenue
- RARE $522,745,000.00
- MOD $2,484,400,000.00
- Revenue This Year
- RARE $26.70
- MOD $9.93
- Revenue Next Year
- RARE $19.02
- MOD $9.07
- P/E Ratio
- RARE N/A
- MOD $45.90
- Revenue Growth
- RARE 27.44
- MOD 2.62
- 52 Week Low
- RARE $37.02
- MOD $60.00
- 52 Week High
- RARE $60.37
- MOD $146.84
- Technical
- Relative Strength Index (RSI)
- RARE 40.43
- MOD 68.07
- Support Level
- RARE $39.99
- MOD $114.63
- Resistance Level
- RARE $44.52
- MOD $129.00
- Average True Range (ATR)
- RARE 2.18
- MOD 5.10
- MACD
- RARE -0.03
- MOD 2.41
- Stochastic Oscillator
- RARE 17.75
- MOD 99.88
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About MOD Modine Manufacturing Company
Modine Manufacturing Co provides thermal management solutions to diversified markets and customers. The company provides engineered heat transfer systems and heat transfer components for use in on- and off-highway original equipment manufacturer (OEM) vehicular applications in the United States. It offers powertrain cooling products, such as engine cooling assemblies, radiators, condensers, and charge air coolers; auxiliary cooling products, including power steering and transmission oil coolers.